Microbiomes in HIV and at-risk populations - an evolving mystery
Published in Microbiology
Healthy adult gut microbiomes can be stratified into groups defined largely by the relative dominance of bacteria in the genus Prevotella versus Bacteroides. In general, Bacteroides-rich microbiomes are more common in people eating a typical western diet – high fat and low fiber – whereas relatively Prevotella-rich microbiomes are observed in agrarian cultures and in individuals in the US who consume less animal product and more carbohydrates and fiber and has been generally seen as healthy.
However, potential negative health implications for Prevotella-rich microbiomes have been discussed in several health contexts including insulin resistance and rheumatoid arthritis. Prevotella richness has also been described in several initial microbiome studies of Americans with HIV infection. Understanding context-specific differences in Prevotella-rich microbiomes may help deconvolute how it associates with diet and impacts disease.
When initiating a new HIV microbiome study we decided to recruit our non-disease controls from people who were more similar to those living with HIV, this meant primarily men who have sex with men (MSM), a population disproportionately affected by HIV in the US. Much to our surprise, the gut microbiome of our MSM, HIV negative controls no longer showed strong differences from HIV positive people, suggesting Prevotella richness might be associated with MSM and not HIV. Our suspicions were quickly confirmed when another group based in Spain published a similar result.
Given these surprising findings we had two main questions we wanted to answer: 1) Is the microbiome composition in Prevotella-rich MSM differed from Prevotella-rich non-MSM? 2) Are there still HIV-specific changes despite the large MSM confounder? In short, the answer to both is ‘yes’!
In our study we showed that Prevotella-rich microbiomes in MSM had a different species composition than Prevotella-rich microbiomes in non-MSM. Many of these MSM-associated microbes are often implicated in inflamed guts and other diseases. We’ve confirmed this with other studies in our lab that showed MSM microbiomes and some of the associated microbes were more inflammatory (Neff et al. 2018, Lozupone et al. 2014). Taken together, this suggests that there may be a disease-type and a healthy, diet-type Prevotella-rich microbiome.
This marked MSM microbiome difference also led us to the question ‘why are these different?’. Unfortunately, we still do not know what drives a Prevotella-rich microbiome in MSM. We had suspected that sexual practices may be a factor, but found no evidence for this in our data.
Additionally, although the microbiome differences between HIV positive and HIV negative MSM were relatively subtle, the differences that we do show are an increase bacteria sometimes found in opportunistic infections. In our other work we have found these microbiomes to induce high inflammation in mouse studies, indicating that these subtle differences may be functionally significant (Neff et al. 2018).
All in all, we still have much to learn about the MSM and HIV-associated gut microbiome and its health implications, as well as the functional properties of Prevotella-rich microbiomes observed in health versus disease contexts. The more we know about these potentially unhealthy microbiomes the more likely we might be to find treatments that focus on the microbiome to promote health in HIV infected and high-risk populations.
The paper in the journal Microbiome can be found here.
References
Armstrong AJS, Shaffer M, Nusbacher NM, Griesmer C, Fiorillo S, Schneider JM, Preston Neff C, Li SX, Fontenot AP, Campbell T, Palmer BE, Lozupone CA. 2018. An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men. Microbiome 6:198.
Lozupone CA, Rhodes ME, Neff CP, Fontenot AP, Campbell TB, Palmer BE. 2014. HIV-induced alteration in gut microbiota. Gut Microbes 5:562-570.
Neff CP, Krueger O, Xiong K, Arif S, Nusbacher N, Schneider JM, Cunningham AW, Armstrong A, Li S, McCarter MD, Campbell TB, Lozupone CA, Palmer BE. 2018. Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals. EBioMedicine 30:192-202.
Follow the Topic
-
Microbiome
This journal hopes to integrate researchers with common scientific objectives across a broad cross-section of sub-disciplines within microbial ecology. It covers studies of microbiomes colonizing humans, animals, plants or the environment, both built and natural or manipulated, as in agriculture.
Related Collections
With Collections, you can get published faster and increase your visibility.
Oncobiome
This collection of papers delves into the burgeoning field of oncobiome research, exploring the intricate relationship between cancer and the microbiome. The oncobiome encompasses the diverse microbial communities residing in and on the human body, which influence cancer development, progression, and treatment responses. By examining these interactions, our aim is to unravel the complex mechanisms through which the microbiome impacts oncogenesis and therapeutic outcomes.
This compilation highlights cutting-edge research, offering insights into potential diagnostic markers and novel therapeutic strategies, thereby advancing our understanding of cancer biology and paving the way for innovative, microbiome-targeted cancer treatments.
This is a cross-journal collection between:
Experimental Hematology and Oncology
Articles will undergo the standard peer-review process of the journal to which they are submitted and are subject to either the BMC editorial policies or those of BJC Reports. Articles will be added to the Collection as they are published. The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
Publishing Model: Open Access
Deadline: Ongoing
The Apple Microbiome
Microbiome and Environmental Microbiome are calling for submissions to our Collection on the Apple Microbiome.
With world apple production estimated at 84 million tons, the microbiome of the apple has significant implications for agriculture, food security, and human health. Understanding the complex interactions between apple plants and their associated microbial communities can lead to improved crop management strategies, enhanced fruit quality and longevity, and sustainable agricultural practices. Recent advances have highlighted the role of specific bacteria and fungi in promoting plant health and resilience against specific pathogens. Moreover, detailed profiling of these microbial communities, revealing their diversity and functional potential facilitate exciting future developments, such as the identification of beneficial microbial consortia for biocontrol and the formulation of tailored probiotic treatments for both plants and humans. By advancing our collective understanding in this area, we can work towards a more sustainable and resilient agricultural system.
Topics of interest include but are not limited to:
-Microbial diversity and function associated with apples
-Effects of soil health and rhizosphere interactions on apple production
-Impact of climate change on the apple microbiome
-Role of the apple microbiome in fruit quality
-Microbiome-driven strategies for disease resistance
This collection is open for submissions from all authors on the condition that the manuscript falls within both the scope of the collection and the journal it is submitted to.
All submissions in this collection undergo the relevant journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief of the relevant journal. As an open access publication, participating journals levy an article processing fee (Microbiome, Environmental Microbiome). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief of the journal where the article is being submitted.
Publishing Model: Open Access
Deadline: Sep 30, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in